| Primary |
| Product Used For Unknown Indication |
66.7% |
| Asthma |
33.3% |
|
|
| Secondary |
| Asthma |
15.9% |
| Bronchitis |
14.1% |
| Pneumonia |
10.9% |
| Respiratory Disorder |
10.1% |
| Pancreatic Carcinoma |
8.7% |
| Insomnia |
6.9% |
| Dyspnoea |
4.7% |
| Cough |
4.3% |
| Hypertension |
3.3% |
| Upper Respiratory Tract Inflammation |
2.9% |
| Abdominal Pain |
2.2% |
| Diabetes Mellitus |
2.2% |
| Drug Use For Unknown Indication |
2.2% |
| Oral Herpes |
2.2% |
| Influenza |
1.8% |
| Pyrexia |
1.8% |
| Back Pain |
1.4% |
| Depression |
1.4% |
| Gastric Ulcer |
1.4% |
| Hyperlipidaemia |
1.4% |
|
| Tremor |
14.6% |
| Hepatic Function Abnormal |
12.5% |
| Pyrexia |
8.3% |
| Stevens-johnson Syndrome |
8.3% |
| Insomnia |
6.3% |
| Pneumonia Aspiration |
6.3% |
| Rash |
6.3% |
| Feeling Abnormal |
4.2% |
| Platelet Count Increased |
4.2% |
| Rhabdomyolysis |
4.2% |
| Somnolence |
4.2% |
| Toxic Epidermal Necrolysis |
4.2% |
| Cardio-respiratory Arrest |
2.1% |
| Cardiomyopathy |
2.1% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
2.1% |
| Dysarthria |
2.1% |
| Dysgeusia |
2.1% |
| Hallucination |
2.1% |
| Hypoaesthesia |
2.1% |
| Hyposmia |
2.1% |
|
| Concomitant |
| Asthma |
23.7% |
| Product Used For Unknown Indication |
20.2% |
| Bronchitis |
6.2% |
| Hypertension |
5.9% |
| Drug Use For Unknown Indication |
5.1% |
| Pneumonia |
5.1% |
| Prophylaxis |
4.8% |
| Chronic Obstructive Pulmonary Disease |
3.5% |
| Cough |
3.3% |
| Rheumatoid Arthritis |
3.0% |
| Influenza |
2.9% |
| Insomnia |
2.8% |
| Constipation |
2.2% |
| Gastritis |
2.1% |
| Cardiac Failure |
1.7% |
| Diabetes Mellitus |
1.6% |
| Upper Respiratory Tract Inflammation |
1.6% |
| Emphysema |
1.5% |
| Spinal Osteoarthritis |
1.5% |
| Angina Pectoris |
1.3% |
|
| Asthma |
11.4% |
| Vomiting |
9.2% |
| Abnormal Behaviour |
8.9% |
| Hepatic Function Abnormal |
7.0% |
| Interstitial Lung Disease |
5.8% |
| Pneumonia |
5.6% |
| Rhabdomyolysis |
5.6% |
| White Blood Cell Count Decreased |
5.0% |
| Hypoglycaemia |
4.7% |
| Ventricular Fibrillation |
3.9% |
| Renal Impairment |
3.6% |
| Wheezing |
3.6% |
| Cardiac Failure |
3.3% |
| Death |
3.3% |
| Pyrexia |
3.3% |
| Respiratory Failure |
3.3% |
| Restlessness |
3.3% |
| Bronchitis |
3.1% |
| Delirium |
3.1% |
| Loss Of Consciousness |
2.8% |
|
| Interacting |
| Type 1 Diabetes Mellitus |
28.6% |
| Asthma |
14.3% |
| Diabetic Neuropathy |
14.3% |
| Hypertension |
14.3% |
| Benign Prostatic Hyperplasia |
7.1% |
| Chronic Obstructive Pulmonary Disease |
7.1% |
| Musculoskeletal Stiffness |
7.1% |
| Rhinitis Allergic |
7.1% |
|
|
